Multiple Differences in Gene Expression in Regulatory V 24J Q T

Total Page:16

File Type:pdf, Size:1020Kb

Multiple Differences in Gene Expression in Regulatory V 24J Q T Multiple differences in gene expression in regulatory V␣24J␣Q T cells from identical twins discordant for type I diabetes S. Brian Wilson*†, Sally C. Kent‡, Heidi F. Horton§, Andrew A. Hill§, Paul L. Bollyky¶, David A. Hafler‡, Jack L. Stromingerʈ, and Michael C. Byrne§† *Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, MA 02115; ‡Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA 02115; §Genetics Institute, Cambridge, MA 02140; ¶Harvard Medical School, Boston, MA 02115; and ʈDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138 Contributed by Jack L. Strominger, April 10, 2000 Quantitative and qualitative defects in CD1d-restricted T cells calcium flux determination was performed by using a MoFlo have been demonstrated in human and murine autoimmune cytometer (Cytomation, Fort Collins, NJ) as described (8). diseases. To investigate the transcriptional consequences of T cell receptor activation in human V␣24J␣Q T cell clones, DNA Cell Culture. Single V␣24-positive, CD4͞8-negative single-cell microarrays were used to quantitate changes in mRNA levels sorts were grown on irradiated allogeneic feeders at 50,000 after anti-CD3 stimulation of clones derived from identical twins cells per well with 5,000 cells per well irradiated (5,000 rads) discordant for type 1 diabetes and IL-4 secretion. Activation 721.221 lymphoblastoid cells with 1 ␮g͞ml PHA-P, IL-2, and resulted in significant modulation of 226 transcripts in the IL-4 IL-7 each at 10 units͞ml (Boehringer Mannheim) and prop- secreting clone and 86 in the IL-4-null clone. Only 28 of these agated as described (8). Clones positive for V␣24 and NKR- genes were in common. The differences observed suggest both P1A by flow cytometry and a V␣24J␣Q CDR3 T cell antigen ineffective differentiation of diabetic V␣24J␣Q T cells and a role receptor sequence were assayed for cytokine secretion in ͞ for invariant T cells in the recruitment and activation of cells C1R CD1d restriction experiments. For cytokine secretion IMMUNOLOGY ␣ ␣ from the myeloid lineage. and inhibitor studies, V 24J Q T cell clones GW4 (nondia- betic) and ME10 (diabetic) at 5 ϫ 104 cells per well were activated with plate-bound anti-CD3 or Ig control at 1 ␮g͞ml. nvariant CD161ϩ T cells are reported to be important in the Secreted IL-4 and IFN-␥ were assayed by ELISA after4hof Iregulation of T helper cell (Th) Th1͞Th2 bias (1). In several ϩ ␣ ␣ activation as described (8). Optimal concentrations of inhib- murine models of autoimmunity, CD161 V 14J 281 T cells itors previously were determined by inhibitor dose–response were shown to be present in diminished numbers and to further experiments. The concentrations of inhibitors used were 10 decrease in frequency before the onset of disease (2–4). When nM wortmannin; 10 ␮M LY294002; 50 ␮M PD98059, a this population of cells was transferred from either nonobese ␮ ͞ ␣ ␣ mitogen-activated protein kinase kinase inhibitor; and 50 M nondiabetic (NOD) or nonobese diabetic V 14J 281- SB203580, a p38 kinase inhibitor. The concentrations of transgenic donors to prediabetic animals, the recipients were phorbol ester and calcium ionophore used were 1 ng͞ml protected from diabetes (4, 5). This transfer of protection was phorbol 12-myristate 13-acetate (PMA) and 1 ␮g͞ml ionomy- significantly inhibited by the coadministration of anti-IL-4 an- cin. Cyclosporin A (CsA) was used at 5 ng͞ml. Calcium flux tibodies (6). was determined by loading cells with indo-1 as per the Humans have a homologous invariant (i.e., with no N region manufacturer’s specifications (Molecular Probes), followed by ϩ ␣ ␣ additions) CD161 V 24J Q T cell population whose restriction activation with anti-CD3 at 10 ␮g͞ml. Maximal calcium flux element, like that for the murine CD161ϩV␣14J␣281 T cells, is the was determined by the addition of ionomycin. nonpolymorphic class Ib molecule CD1d (7). We recently demon- strated that in five sets of monozygotic twins and triplets discordant Messenger RNA Expression. V␣24J␣Q T cell clones GW4 and for type 1 diabetes, invariant V␣24J␣Q T cells were present at ME10 (1 ϫ 107 cells) were activated for4hwith10␮g͞ml significantly higher frequencies in the nondiabetic siblings (8). soluble anti-CD3 or control IgG. Optimal concentrations of Moreover, V␣24J␣Q T-cell clones from the nondiabetic siblings anti-CD3 previously were determined by dose–response ex- secreted both IL-4 and IFN-␥, whereas those derived from the periments measuring cytokine secretion. Total RNA was diabetic siblings had an extreme impairment in the ability to secrete isolated with Qiagen RNeasy kits. Total RNA then was IL-4. To delineate differences in gene expression that might ac- converted to double-stranded cDNA by priming with an count for the discordant phenotype and to ask whether the loss of oligo(dT) primer that included a T7 RNA polymerase pro- IL-4 secretion was the only defect, a comprehensive analysis of T moter site at the 5Ј end (11). The cDNA was used directly in cell activation was undertaken in a representative clone pair derived an in vitro transcription reaction in the presence of biotinylated from these disease-discordant twins. nucleotides to produce labeled cRNA (antisense RNA), which Methods Abbreviations: Th, T helper; PI3-kinase, phosphoinositide-3-OH kinase; PMA, phorbol Antibodies. Anti-V␣24, -V␤11, and -␣␤TCR were purchased 12-myristate 13-acetate. from Immunotech (Westbrook, ME). Anti-CD4, -CD8, and See commentary on page 6933. -CD161 were purchased from PharMingen. Anti-CD3, clone †To whom reprint requests should be addressed. E-mail: [email protected] (M.C.B.) or [email protected] (S.B.W.). UCHT1, was purchased from Ancell (Bayport, MN), and IgG1 The publication costs of this article were defrayed in part by page charge payment. This control was purchased from Sigma. article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact. Flow Cytometry. Stained cells were analyzed on a FACScan Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073͞pnas.120161297. cytometer (Beckton Dickinson), and single-cell sorting and Article and publication date are at www.pnas.org͞cgi͞doi͞10.1073͞pnas.120161297 PNAS ͉ June 20, 2000 ͉ vol. 97 ͉ no. 13 ͉ 7411–7416 Downloaded by guest on September 25, 2021 Fig. 1. Discordant expression of PI3-kinase-regulated events differentiates IL-4ϩ from IL-4-null V␣24J␣Q T cell clones. (A)V␣24J␣Q T cell clones GW4 (nondiabetic) and ME10 (diabetic) were activated with plate-bound anti-CD3 or Ig control. Levels of secreted IL-4 and IFN-␥ were assayed by ELISA. The concentrations of inhibitors used were 10 nM wortmannin (wort.); 10 ␮M LY294002 (LY); 50 ␮M PD98059 (PD), a mitogen-activated protein kinase kinase inhibitor; and 50 ␮M SB203580 (SB), a p38 kinase inhibitor. Data points were collected in triplicate, and the Fig. is representative of four independent experiments. The concentrations of phorbol ester and calcium ionophore used were 1 ng͞ml PMA and 1 ␮g͞ml ionomycin (Iono). Cyclosporin A (CsA) was used at 5 ng͞ml. (B)V␣24J␣Q T cell clones GW4 (IL-4ϩ) and ME10 (IL-4-null), 1 ϫ 106 cells each, were loaded with Indo-1 (10 ␮M) for 45 min, then stimulated with 10 ␮g͞ml anti-CD3 (open arrowhead) and analyzed on a Cytomation MoFlo instrument. At the end of the experiment, ionomycin was added to a final concentration of 1 ␮g͞ml (filled arrowhead) to determine maximal flux. The ratio of Indo-1 fluorescence 410͞490 nm (410, Ca2ϩ-bound; 490, Ca2ϩ-free) after stimulation in a representative pair of clones is pictured. Control experiments showed no differences in calcium flux in response to thapsigargin treatment (data not shown). was hybridized overnight to Genechips (Affymetrix, San Jose, Because the defect in IL-4 secretion was likely the result of CA). After staining with phycoerythrin-streptavidin, the flu- multiple differences, a representative clone pair was chosen for orescence of bound RNA was quantitated by using a Genechip intensive analysis with DNA microarrays that monitor the expres- Reader (a modified confocal microscope; Affymetrix). sion of Ϸ6,800 genes (Unigene collection; National Center for Biotechnology Information, Bethesda, MD). The DNA microar- Results and Discussion rays provide a practical and reproducible approach for large-scale To identify which of the known signaling cascades initiated by T study of complex differences in gene expression (11–14). Expres- cell antigen receptor ligation played a dominant role in IL-4 sion profiles were determined after4hofstimulationwithanti-CD3 secretion, a series of inhibitor studies was performed. Inhibitors or control IgG. This time point was selected because it was used in of specific kinase cascades were used in conjunction with anti- a previous analysis of cytokine secretion in clones derived from CD3 stimulation. Both phosphoinositide-3-OH kinase (PI3- monozygotic twin pairs discordant for type 1 diabetes (8). The kinase) inhibitors wortmannin and LY294002 blocked anti-CD3- number of genes with detectable expression either before or after induced IL-4 secretion from the IL-4ϩ clone, but had no effect stimulation was nearly identical for the IL-4 null and IL-4-secreting on the secretion of IFN-␥ from either the IL-4ϩ or IL-4-null clones (1,523 and 1,558, respectively). As expected, the frequency clones (Fig. 1). In contrast, inhibition of the mitogen-activated of the majority of transcripts was unchanged. Interestingly, only protein kinase kinase by PD98059 or the JNK and p38 cascades ͞ with SB203580 (9, 10) had no effect. After inhibition of PI3- about 2 3 of this set (988) were shared between the two clones. The kinase, IL-4 secretion could be rescued in the IL-4ϩ clone by the number of genes whose expression after anti-CD3 stimulation was found to increase or decrease by at least 2-fold relative to unstimu- inclusion of the phorbol ester PMA or the calcium ionophore ϩ ionomycin.
Recommended publications
  • Nucleolin and Its Role in Ribosomal Biogenesis
    NUCLEOLIN: A NUCLEOLAR RNA-BINDING PROTEIN INVOLVED IN RIBOSOME BIOGENESIS Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Julia Fremerey aus Hamburg Düsseldorf, April 2016 2 Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: Prof. Dr. A. Borkhardt Korreferent: Prof. Dr. H. Schwender Tag der mündlichen Prüfung: 20.07.2016 3 Die vorgelegte Arbeit wurde von Juli 2012 bis März 2016 in der Klinik für Kinder- Onkologie, -Hämatologie und Klinische Immunologie des Universitätsklinikums Düsseldorf unter Anleitung von Prof. Dr. A. Borkhardt und in Kooperation mit dem ‚Laboratory of RNA Molecular Biology‘ an der Rockefeller Universität unter Anleitung von Prof. Dr. T. Tuschl angefertigt. 4 Dedicated to my family TABLE OF CONTENTS 5 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................... 5 LIST OF FIGURES ......................................................................................................10 LIST OF TABLES .......................................................................................................12 ABBREVIATION .........................................................................................................13 ABSTRACT ................................................................................................................19 ZUSAMMENFASSUNG
    [Show full text]
  • Cancer Stem Cells and Nucleolin As Drivers of Carcinogenesis
    pharmaceuticals Review Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis Laura Sofia Carvalho 1,Nélio Gonçalves 1 , Nuno André Fonseca 1,2 and João Nuno Moreira 1,3,* 1 CNC—Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine (Polo 1), University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal; laurasofi[email protected] (L.S.C.); [email protected] (N.G.); [email protected] (N.A.F.) 2 TREAT U, SA—Parque Industrial de Taveiro, Lote 44, 3045-508 Coimbra, Portugal 3 UC—University of Coimbra, CIBB, Faculty of Pharmacy (FFUC), Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal * Correspondence: [email protected]; Tel.: +351-239-820-190 Abstract: Cancer, one of the most mortal diseases worldwide, is characterized by the gain of specific features and cellular heterogeneity. Clonal evolution is an established theory to explain heterogeneity, but the discovery of cancer stem cells expanded the concept to include the hierarchical growth and plasticity of cancer cells. The activation of epithelial-to-mesenchymal transition and its molecular players are widely correlated with the presence of cancer stem cells in tumors. Moreover, the acquisition of certain oncological features may be partially attributed to alterations in the levels, location or function of nucleolin, a multifunctional protein involved in several cellular processes. This review aims at integrating the established hallmarks of cancer with the plasticity of cancer cells as an emerging hallmark; responsible for tumor heterogeneity; therapy resistance and relapse. The discussion will contextualize the involvement of nucleolin in the establishment of cancer hallmarks and its application as a marker protein for targeted anticancer therapies Keywords: tumor heterogeneity; drug resistance; cancer stem cells; nucleolin; targeted therapies; epithelial-to-mesenchymal transition Citation: Carvalho, L.S.; Gonçalves, N.; Fonseca, N.A.; Moreira, J.N.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. Phosphoryl I-Area II-Area II-Debunker III-Area Gene Symbol Protein Name Phosphorylated Peptide I-R2 I-Debunker score II-R2 III-R2 ation Site Ratio Ratio score Ratio 92154 ABBA-1 Actin-bundling protein with BAIAP2 homologyK.TPTVPDS*PGYMGPTR.A S601 1.76 0.95 0.999958250 1.18 0.98 0.999971836 0.98 0.98 92154 ABBA-1 Actin-bundling protein with BAIAP2 homologyR.AGS*EECVFYTDETASPLAPDLAK.A S612 1.40 0.99 0.999977464 1.03 0.99 0.999986373 1.00 0.99 92154 ABBA-1 Actin-bundling protein with BAIAP2 homologyK.GGGAPWPGGAQTYS*PSSTCR.Y S300 0.49 0.98 0.999985406 0.97 0.99 0.999983906 2.03 0.97 23 ABCF1 ATP-binding cassette sub-family F memberK.QQPPEPEWIGDGESTS*PSDK.V 1 S22 1.09 0.98 0.872361494 0.81 1.00 0.847115585 0.97 0.97 27 ABL2 Isoform IA of Tyrosine-protein kinase ABL2K.VPVLIS*PTLK.H S936 0.76 0.98 0.999991559 1.06 0.99 0.999989547 0.99 0.96 3983 ABLIM1 Actin binding LIM protein 1 R.TLS*PTPSAEGYQDVR.D S433 1.27 0.99 0.999994010 1.16 0.98 0.999989861 1.11 0.99 31 ACACA acetyl-Coenzyme A carboxylase alpha isoformR.FIIGSVSEDNS*EDEISNLVK.L 1 S29 1.23 0.99 0.999992898 0.72 0.99 0.999992499 0.83 0.99 65057 ACD Adrenocortical dysplasia protein homologR.TPS*SPLQSCTPSLSPR.S S424 1.51 0.90 0.999936226 0.82 0.88 0.997623142 0.46 0.93 22985 ACIN1 Apoptotic chromatin condensation inducerK.ASLVALPEQTASEEET*PPPLLTK.E in the nucleus T414 0.90 0.92 0.922696554 0.91 0.92 0.993049132 0.95 0.99 22985 ACIN1 Apoptotic chromatin condensation inducerK.ASLVALPEQTAS*EEETPPPLLTK.E in the nucleus S410 1.02 0.99 0.997470008 0.80 0.99 0.999702808 0.96
    [Show full text]
  • The Role of Nucleolin in B-Cell Lymphomas and Fas-Mediated Apoptotic Signaling
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2013 The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling Jillian F. Wise Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Cancer Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Wise, Jillian F., "The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling" (2013). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 339. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/339 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling by Jillian F Wise, BS Approved: ___________________________________________________ Felipe
    [Show full text]
  • The Role of Nucleolin Phosphorylation by CK2 in Regulating Cellular Fate Under Normal and Stress Conditions
    City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 9-2017 The Role of Nucleolin Phosphorylation by CK2 in Regulating Cellular Fate Under Normal and Stress Conditions Shu Xiao The Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/2412 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] THE ROLE OF NUCLEOLIN PHOSPHORYLATION BY CK2 IN REGULATING CELLULAR FATE UNDER NORMAL AND STRESS CONDITIONS by Shu Xiao A dissertation submitted to the Graduate Faculty in Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2017 © 2017 Shu Xiao All Rights Reserved ii The role of nucleolin phosphorylation by CK2 in regulating cellular fate under normal and stress conditions by Shu Xiao This manuscript has been read and accepted for the Graduate Faculty in Biology in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. Anjana Saxena Date Chair of Examining Committee Cathy Savage-Dunn Date Executive Officer Supervising Committee: Frida Kleiman Xinyin Jiang Jimmie Fata James Borowiec THE CITY UNIVERSITY OF NEW YORK iii ABSTRACT The role of nucleolin phosphorylation by CK2 in regulating cellular fate under normal and stress conditions by Shu Xiao Advisor: Dr. Anjana Saxena Nucleolin (NCL or C23) is an abundant genotoxic stress-responsive RNA binding phosphoprotein.
    [Show full text]
  • Interplay of RNA-Binding Proteins and Micrornas in Neurodegenerative Diseases
    International Journal of Molecular Sciences Review Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases Chisato Kinoshita 1,* , Noriko Kubota 1,2 and Koji Aoyama 1,* 1 Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan; [email protected] 2 Teikyo University Support Center for Women Physicians and Researchers, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan * Correspondence: [email protected] (C.K.); [email protected] (K.A.); Tel.: +81-3-3964-3794 (C.K.); +81-3-3964-3793 (K.A.) Abstract: The number of patients with neurodegenerative diseases (NDs) is increasing, along with the growing number of older adults. This escalation threatens to create a medical and social crisis. NDs include a large spectrum of heterogeneous and multifactorial pathologies, such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and multiple system atrophy, and the formation of inclusion bodies resulting from protein misfolding and aggregation is a hallmark of these disorders. The proteinaceous components of the pathological inclusions include several RNA-binding proteins (RBPs), which play important roles in splicing, stability, transcription and translation. In addition, RBPs were shown to play a critical role in regulating miRNA biogenesis and metabolism. The dysfunction of both RBPs and miRNAs is Citation: Kinoshita, C.; Kubota, N.; often observed in several NDs. Thus, the data about the interplay among RBPs and miRNAs and Aoyama, K. Interplay of RNA-Binding Proteins and their cooperation in brain functions would be important to know for better understanding NDs and microRNAs in Neurodegenerative the development of effective therapeutics.
    [Show full text]
  • Live-Cell Imaging Rnai Screen Identifies PP2A–B55α and Importin-Β1 As Key Mitotic Exit Regulators in Human Cells
    LETTERS Live-cell imaging RNAi screen identifies PP2A–B55α and importin-β1 as key mitotic exit regulators in human cells Michael H. A. Schmitz1,2,3, Michael Held1,2, Veerle Janssens4, James R. A. Hutchins5, Otto Hudecz6, Elitsa Ivanova4, Jozef Goris4, Laura Trinkle-Mulcahy7, Angus I. Lamond8, Ina Poser9, Anthony A. Hyman9, Karl Mechtler5,6, Jan-Michael Peters5 and Daniel W. Gerlich1,2,10 When vertebrate cells exit mitosis various cellular structures can contribute to Cdk1 substrate dephosphorylation during vertebrate are re-organized to build functional interphase cells1. This mitotic exit, whereas Ca2+-triggered mitotic exit in cytostatic-factor- depends on Cdk1 (cyclin dependent kinase 1) inactivation arrested egg extracts depends on calcineurin12,13. Early genetic studies in and subsequent dephosphorylation of its substrates2–4. Drosophila melanogaster 14,15 and Aspergillus nidulans16 reported defects Members of the protein phosphatase 1 and 2A (PP1 and in late mitosis of PP1 and PP2A mutants. However, the assays used in PP2A) families can dephosphorylate Cdk1 substrates in these studies were not specific for mitotic exit because they scored pro- biochemical extracts during mitotic exit5,6, but how this relates metaphase arrest or anaphase chromosome bridges, which can result to postmitotic reassembly of interphase structures in intact from defects in early mitosis. cells is not known. Here, we use a live-cell imaging assay and Intracellular targeting of Ser/Thr phosphatase complexes to specific RNAi knockdown to screen a genome-wide library of protein substrates is mediated by a diverse range of regulatory and targeting phosphatases for mitotic exit functions in human cells. We subunits that associate with a small group of catalytic subunits3,4,17.
    [Show full text]
  • Integrative Framework for Identification of Key Cell Identity Genes Uncovers
    Integrative framework for identification of key cell PNAS PLUS identity genes uncovers determinants of ES cell identity and homeostasis Senthilkumar Cinghua,1, Sailu Yellaboinaa,b,c,1, Johannes M. Freudenberga,b, Swati Ghosha, Xiaofeng Zhengd, Andrew J. Oldfielda, Brad L. Lackfordd, Dmitri V. Zaykinb, Guang Hud,2, and Raja Jothia,b,2 aSystems Biology Section and dStem Cell Biology Section, Laboratory of Molecular Carcinogenesis, and bBiostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709; and cCR Rao Advanced Institute of Mathematics, Statistics, and Computer Science, Hyderabad, Andhra Pradesh 500 046, India Edited by Norbert Perrimon, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, and approved March 17, 2014 (received for review October 2, 2013) Identification of genes associated with specific biological pheno- (mESCs) for genes essential for the maintenance of ESC identity types is a fundamental step toward understanding the molecular resulted in only ∼8% overlap (8, 9), although many of the unique basis underlying development and pathogenesis. Although RNAi- hits in each screen were known or later validated to be real. The based high-throughput screens are routinely used for this task, lack of concordance suggest that these screens have not reached false discovery and sensitivity remain a challenge. Here we describe saturation (14) and that additional genes of importance remain a computational framework for systematic integration of published to be discovered. gene expression data to identify genes defining a phenotype of Motivated by the need for an alternative approach for iden- interest. We applied our approach to rank-order all genes based on tification of key cell identity genes, we developed a computa- their likelihood of determining ES cell (ESC) identity.
    [Show full text]
  • Energy-Dependent Nucleolar Localization of P53 in Vitro Requires Two Discrete Regions Within the P53 Carboxyl Terminus
    Oncogene (2007) 26, 3878–3891 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc ORIGINAL ARTICLE Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus O Karni-Schmidt1, A Friedler2,3, A Zupnick1, K McKinney1, M Mattia1, R Beckerman1, P Bouvet4, M Sheetz1, A Fersht2 and C Prives1 1Department of Biological Sciences, Columbia University, New York, USA; 2Department of MRC-CPE, Center for Protein Engineering, Medical Research Council, Cambridge, UK; 3Department of Organic Chemistry, The Hebrew University of Jerusalem, Givat Ram, Jerusalem, Israel; 4Laboratoire de Biologie Mole´culaire de la Cellule/UMR 5161, Ecole Normale Supe´rieure de Lyon 46, Alle´e d’Italie 69364 Lyon Cedex, France The p53 tumor suppressor is a nucleocytoplasmic shuttling concentration, is presumably inactive as a transcription protein that is found predominantly in the nucleus of cells. factor and is diffusely distributed throughout the cell. In In addition to mutation, abnormal p53 cellular localiza- response to DNA damage or other forms of cellular tion is one of the mechanisms that inactivate p53 function. stress, p53 protein accumulates, frequently becomes To further understand features of p53 that contribute to extensively post-translationally modified and concen- the regulation of its trafficking within the cell, we analysed trates within the nucleus (Giaccia and Kastan, 1998; the subnuclear localization of wild-type and mutant p53 in Appella and Anderson, 2001; Liang and Clarke, 2001; human cells that were either permeabilized with detergent Prives and Manley, 2001). or treated with the proteasome inhibitor MG132.
    [Show full text]
  • Telomerase Reverse Transcriptase Promotes Cancer Cell Proliferation by Augmenting Trna Expression
    The Journal of Clinical Investigation RESEARCH ARTICLE Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression Ekta Khattar,1 Pavanish Kumar,2 Chia Yi Liu,1 Semih Can Akıncılar,1 Anandhkumar Raju,1 Manikandan Lakshmanan,1 Julien Jean Pierre Maury,3 Yu Qiang,4 Shang Li,5 Ern Yu Tan,6 Kam M. Hui,5,7,8,9 Ming Shi,10 Yuin Han Loh,3 and Vinay Tergaonkar1,11 1Division of Cancer Genetics and Therapeutics, Laboratory of NFκB Signaling, Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research),Singapore. 2Singapore Immunology Network, A*STAR, Singapore. 3Epigenetics and Cell Fates Laboratory, IMCB, A*STAR, Singapore. 4Genome Institute of Singapore, A*STAR, Singapore. 5Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore. 6Department of General Surgery, Tan Tock Seng Hospital, Singapore. 7National Cancer Centre, Singapore. 8Institute of Molecular and Cell Biology, A*STAR, Singapore. 9Department of Biochemistry, Yong Loo Lin School of Medicine, NUS, Singapore. 10Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. 11Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Transcriptional reactivation of telomerase reverse transcriptase (TERT) reconstitutes telomerase activity in the majority of human cancers. Here, we found that ectopic TERT expression increases cell proliferation, while acute reductions in TERT levels lead to a dramatic loss of proliferation without any change in telomere length, suggesting that the effects of TERT could be telomere independent. We observed that TERT determines the growth rate of cancer cells by directly regulating global protein synthesis independently of its catalytic activity.
    [Show full text]
  • Altered Nucleophosmin Transport in Acute Myeloid Leukaemia with Mutated NPM1: Molecular Basis and Clinical Implications
    Leukemia (2009) 23, 1731–1743 & 2009 Macmillan Publishers Limited All rights reserved 0887-6924/09 $32.00 www.nature.com/leu REVIEW Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications B Falini1, N Bolli1,5, A Liso2, MP Martelli1, R Mannucci3, S Pileri4 and I Nicoletti3 1The Institute of Haematology, University of Perugia, IBiT Foundation, Fondazione IRCCS Biotecnologie nel Trapianto, Perugia, Italy; 2Institute of Haematology, University of Foggia, Foggia, Italy; 3Institute of Internal Medicine, University of Perugia, Perugia, Italy and 4Unit of Haematopathology, Policlinico S. Orsola, University of Bologna, Bologna, Italy Nucleophosmin (NPM1) is a highly conserved nucleo-cytoplas- n. NM_001037738) with a distinct C-terminus; it accounts for mic shuttling protein that shows a restricted nucleolar localiza- minimal nucleophosmin content in tissues. NPM1 (B23.1) and tion. Mutations of NPM1 gene leading to aberrant cytoplasmic NPM1.2 (B23.2) have different subcellular distribution patterns:5 dislocation of nucleophosmin (NPMc þ ) occurs in about one 6,7 third of acute myeloid leukaemia (AML) patients that exhibit NPM1 protein is localized only in the nucleolus and NPM1.2 8 distinctive biological and clinical features. We discuss the mainly in the nucleoplasm. A third variant (accession number latest advances in the molecular basis of nucleophosmin traffic NM_199185) lacks an alternate in-frame exon compared with under physiological conditions, describe the molecular ab- variant 1, resulting in a shorter protein whose functions and normalities underlying altered transport of nucleophosmin in expression pattern are unknown. NPM1-mutated AML and present evidences supporting the view that cytoplasmic nucleophosmin is a critical event for leukae- Experiments on NPM1/B23 migration in interspecies (chick- mogenesis.
    [Show full text]
  • Modulation of Gene Expression by RNA Binding Proteins: Mrna Stability and Translation
    Chapter 5 Modulation of Gene Expression by RNA Binding Proteins: mRNA Stability and Translation Kotb Abdelmohsen Additional information is available at the end of the chapter http://dx.doi.org/10.5772/48485 1. Introduction Regulation of gene expression is an essential process through which mammalian cells counter the changes in their microenvironment. These changes drive cells to respond to different stimuli that trigger cellular re-programming towards proliferation, differentiation, development, apoptosis, senescence, carcinogenesis, etc. Once mRNAs are transcribed they are subjected to posttranscriptional events that regulate mRNA metabolism including stability and translation. These two processes normally dictate the protein levels encoded by mRNA. RNA-binding proteins (RPBs) that bind mature mRNA sequences normally have an important regulatory effect on the mRNA. RBPs are also named mRNA turnover and translation regulator RBPs (TTR-RBPs) since they are capable of regulating both mRNA stability and translation. This family includes numerous members such as Hu proteins [HuA (HuR), HuB, HuC, and HuD] known to bind AU-rich sequences in the 3’ untranslated region (3’UTR) to enhance mRNA translation or to increase its stability [1, 2]. Other RBPs such as T-cell intracellular antigen 1 (TIA-1), TIA-1- related (TIAR), tristetraprolin (TTP), fragile X mental retardation protein (FMRP), polypyrimidine tract-binding protein (PTB), CUG triple repeats RNA-binding protein (CUGBP), nucleolin, and heterogeneous nuclear ribonucleoproteins (hnRNP) A1, A2, and C1/C2 have been shown to influence mRNA stability or translation through interaction with the 3’UTR, CR or the 5’UTR [3-9]. Hu proteins are among the RBPs that are well characterized.
    [Show full text]